Cargando…
Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
Autor principal: | Li, Xiaofei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694462/ https://www.ncbi.nlm.nih.gov/pubmed/33253894 http://dx.doi.org/10.1016/j.aohep.2020.100295 |
Ejemplares similares
-
Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
por: López-Mendez, Ivan, et al.
Publicado: (2021) -
Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
por: Lopez-Mendez, Ivan, et al.
Publicado: (2021) -
Clinical characteristics and outcome of SARS –CoV-2 infection in patients with cystic fibrosis managed at home
por: Terlizzi, V., et al.
Publicado: (2022) -
Association of Liver Steatosis with Clinical Outcomes in SARS-CoV-2 (COVID-19) Infected Patients
por: Praharaj, D.L., et al.
Publicado: (2022) -
Clinical Features and Outcomes of Asymptomatic Cases of SARS-CoV-2 Infection
por: Wu, Jianguo, et al.
Publicado: (2020)